Natasja G. Lieuwes

Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model

Ludwig J. Dubois, Natasja G. Lieuwes, Alfonso Maresca et al. · Radiotherapy and Oncology · 2009 · 192 citations

Xenograft Tumour Model, Tissue Imaging, Biomedical Imaging +9

Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation

Ludwig J. Dubois, Sarah G.J.A. Peeters, Natasja G. Lieuwes et al. · Radiotherapy and Oncology · 2011 · 166 citations · Full text

Specific Inhibition, Vivo Therapeutic Effect, Biochemistry +10

A Comparative Study of the Hypoxia PET Tracers [18F]HX4, [18F]FAZA, and [18F]FMISO in a Preclinical Tumor Model

Sarah G.J.A. Peeters, Catharina M.L. Zegers, Natasja G. Lieuwes et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 157 citations · Full text

Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells

Kranthi M. Panth, Ralph T. H. Leijenaar, Sara Carvalho et al. · Radiotherapy and Oncology · 2015 · 135 citations

Preclinical evaluation and validation of [ ¹⁸ F]HX4, a promising hypoxia marker for PET imaging

Ludwig J. Dubois, Natasja G. Lieuwes, Marco H.M. Janssen et al. · Proceedings of the National Academy of Sciences · 2011 · 131 citations · Full text

Engineering, Oncologic Imaging, Pet-mri +23